Lantheus Medical sets terms for revived $75m IPO

Lantheus Medical Imaging set the terms for a revived initial public offering that would bring in nearly $75 million at the mid-point.

North Billerica, Mass.-based Lantheus, which makes imaging agents and other diagnostic products, deals primarily in radiopharmaceutical and contrast agents. Last year the company said it planned to price the offering at $12 to $15 per share, for a range of $111.1 million to $138.9 million. At the midpoint of that range, Lantheus would have commanded a fully diluted market capitalization of $370 million. But the company tabled the proposed flotation in July.

Yesterday Lantheus revived the IPO, saying it plans to float nearly 7.9 million shares at a price range of $8.50 to $10.50, with an underwriter’s option for an over-allotment worth another 1.2 million shares.

The company plans to trade on the NASDAQ exchange under the “LNTH” symbol.

The post Lantheus Medical sets terms for revived $75m IPO appeared first on MassDevice.

from MassDevice http://ift.tt/1QEFVMl